Weight loss cuts A-fib events in obese patients
There were two teams, both captained by former United States Men’s National Team players with Jeff Agoos taking command of one (with me in net) and Jimmy Conrad of the other. The artificial pitch that the game took place on increased the speed of play to a frenetic pace with both teams trying to beat each other on the counter attack. It only got faster as the rain fell in the second half. Still, on a harsh field in conditions that were far from dry, the adizero F50 performed with aplomb. Touch on the ball was not compromised, no water got into the boot, and, best of all, the new upper provided a real sense of “second skin” for the player. Being at the back allowed me to see just what the f50 was like from a standing start and for quick sprints.
For the original version including any supplementary images or video, visit http://www.sbnation.com/soccer/2013/11/16/5109666/adizero-f50-hands-one
Over a 15-month period, the intervention group achieved greater reductions in weight compared with the routine care group — 14.3 kg vs. 3.6 kg (P<0.001), the researchers found. The single-center, partially blinded, randomized trial involved 150 overweight and obese ambulatory patientswith a BMI of 32.8 kg/m.2 All patients had symptomatic atrial fibrillation and half the patients were on at least one anti-arrhythmic medication. Patients were randomized in a 1:1 ratio to weight management (intervention) or general lifestyle advice (control) and were followed for a median of 15 months. The weight-loss intervention included a very low calorie diet, meal replacements, a written exercise plan, behavioral modification and in-person clinic visits every three months. Routine care consisted of written and verbal advice on nutrition and exercise.
For the original version including any supplementary images or video, visit http://www.clinicaladvisor.com/weight-loss-cuts-a-fib-events-in-obese-patients/article/321473/
Weight reduction decreases atrial fibrillation and symptom severity
The study was conducted between June 2010 and December 2011 among overweight and obese patients with garcinia cambogia reviews symptomatic atrial fibrillation. Patients underwent a median (midpoint) of 15 months of follow-up. Patients were randomized to weight management (intervention; n = 75) or general lifestyle advice (control; n = 75). Both groups underwent intensive management of cardiometabolic risk factors (hypertension, hyperlipidemia, glucose intolerance, sleep apnea, and alcohol and tobacco use).
For the original version including any supplementary images or video, visit http://medicalxpress.com/news/2013-11-weight-reduction-decreases-atrial-fibrillation.html